NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Ingevity Corporation NGVT
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.2B
▼ 2.7% vs FY2024
EPS · FY25
$-4.61
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-148.6%
Net margin · FY25
-14.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.2B
Revenue, FY2025 · full 12-year series below
Revenue
Net income
The company lost 14 cents on every revenue dollar this year.
Per share
USD -4.61
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-148.6%
Return on equity, FY2025
ROE
Operating margin35.9%
Net margin-14.3%
Return on assets-9.1%
Each USD of equity lost 149 cents this year.
Returned to shareholders
USD 54.9M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 54.9M
Share of profit-32.9%
Consecutive raises—
USD 54.9M in buybacks went back to shareholders in a year without profit.
Growth
−0.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−11.2%
−0.8%
+2.0%
Returned to shareholders
−27.0%
−8.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years−12.4%
Change, 10 years—
The share count shrank 12% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.7B
total assets, end of FY2025
Total assetsUSD 1.7B
EquityUSD 29.7M
CashUSD 78.1M
Gross debtUSD 1.2B
Net debtUSD 1.1B
Current ratio1.33×
Net debt stands at 3806% of equity.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue $B
1.2
1.2
1.2
1.7
1.4
1.2
1.3
1.1
1.0
0.9
1.0
1.0
Operating income $B
0.4
0.4
0.4
0.5
0.4
0.4
0.4
0.3
0.2
0.2
0.2
0.2
EBITDA $B
0.5
0.5
0.5
0.6
0.5
0.5
0.5
0.4
0.3
0.2
0.2
0.2
Income tax $B
0.0
−0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
Net income $B
−0.2
−0.4
−0.0
0.2
0.1
0.2
0.2
0.2
0.1
0.0
0.1
0.1
EPS, diluted $
−4.61
−11.85
−0.15
5.50
2.95
4.37
4.35
3.97
2.97
0.83
1.89
3.06
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−148.6
−104.1
−0.8
30.8
17.9
28.3
54.2
56.1
64.7
11.0
15.5
·
Shares out B
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
46 of 46
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed